Beneficial effects of prophylactic OKT3 in cadaver kidney transplantation: comparison with cyclosporin A in a single-center prospective randomized study.
Goldman
M
M
Hôpital Erasme, Département de Néphrologie, Dialyse et Transplantation, Université Libre de Bruxelles, Belgium.
Abramowicz
D
D
De Pauw
L
L
Marécaux
G
G
Vanderwinden
J M
JM
Kinnaert
P
P
Vereerstraeten
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002102:Cadaver; D003524:Cyclosporins / Q000627:therapeutic use*; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D016853:Muromonab-CD3; D011446:Prospective Studies
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3